Metabolic syndrome and health-related quality of life in obese individuals seeking weight reduction

Obesity

Volumn 16, Issue 1, 2008, Pages 59-63

  Tsai, Adam Gilden ^a   Wadden, Thomas A ^a   Sarwer, David B ^a   Berkowitz, Robert I ^a   Womble, Leslie G ^a   Hesson, Louise A ^a   Phelan, Suzanne ^b   Rothman, Rebecca ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; LIFESTYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; QUALITY OF LIFE; REGRESSION ANALYSIS; WEIGHT REDUCTION;

ADULT; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PSYCHOLOGY; QUALITY OF LIFE; REGRESSION ANALYSIS; WEIGHT LOSS;

NICOTIANA TABACUM;

EID: 39449097900     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.8     Document Type: Article

References (26)

1. Meigs JB, Wilson PW, Fox CS et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
2. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
3. Resnick HE, Jones K, Ruotolo G et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in non-diabetic American Indians: the Strong Heart Study. Diabetes Care 2003;26:861-867.
4. Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
5. Duclos M, Marquez Pereira P, Barat R Gatta B, Roger R Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women. Obes Res 2005;13:1157-1166.
6. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2001;2:73-86.
7. Lidfeldt J, Nyberg P, Nerbrand C et al. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 2003;5:106-112.
8. Raikkonen K, Keltikangas-Jarvinen L, Adlercreutz H, Hautanen A. Psychosocial stress and the insulin resistance syndrome. Metabolism 1996;45:1533-1538.
9. Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO. Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity (Silver Spring) 2007;15:511-521.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and Its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
11. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;1:442-443.
12. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
13. Gandek B, Ware JE Jr, Aaronson NK et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1149-1158.
14. Wadden TA, Foster GD, Sargent SL et al. Randomized controlled trial of lifestyle activity for long-term weight control. Obes Res 2004;12:A51-A52.
15. Wadden TA, Berkowitz RI, Womble LG et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005;353:2111-2120.
16. Steer RA, Cavalleri TA, Leonard DM, Beck AT. Use of the Beck Depression Inventory for primary care to screen for major depression disorders. Gen Hosp Psychiatry 1999;21:106-111.
17. Wadden TA, Foster GD. Weight and Lifestyle Inventory (WALI). Obesity 2006;14(Suppl 2):99S-118S.
18. Wadden TA, Butryn ML, Sarwer DB et al. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Obesity (silver spring) 2006;14(Suppl 2):90S-98S.
19. Dixon JB, Dixon ME, O'Brien PE. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res 2001;9:713-721.
20. Wadden TA, Phelan S. Assessment of quality of life in obese individuals. Obes Res 2002;10:50S-57S.
21. Hassan MK, Joshi AV, Madhavan SS, Amonkar MM. Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes 2003;27:1227-1232.
22. Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev 2001;2:219-229.
23. Fontaine KR, Barofsky I. Obesity and health-related quality of life. Obes Rev 2001;2:173-182.
24. Maciejewski ML, Patrick DL, Williamson DF. A structured review of randomized controlled trials of weight loss showed little improvement in health-related quality of life. J Clin Epidemiol 2005;5:568-578.
25. Dixon JB, Anderson M, Cameron-Smith D, O'Brien PE. Sustained weight loss in obese subjects has benefits that are independent of attained weight. Obes Res 2004;12:1895-1902.
26. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996;19:1138-1141.